These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33481386)

  • 1. A Comparison of Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP) Prostate Cancer Grading Guidelines.
    Epstein JI; Hirsch MS
    Am J Surg Pathol; 2021 Jul; 45(7):1005-1007. PubMed ID: 33481386
    [No Abstract]   [Full Text] [Related]  

  • 2. 2019 Gleason grading recommendations from ISUP and GUPS: broadly concordant but with significant differences.
    Varma M; Shah RB; Williamson SR; Berney DM
    Virchows Arch; 2021 Apr; 478(4):813-815. PubMed ID: 33392799
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of the International Society of Urological Pathology modified Gleason grading system.
    Egevad L; Mazzucchelli R; Montironi R
    Arch Pathol Lab Med; 2012 Apr; 136(4):426-34. PubMed ID: 22458905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Genitourinary Society Pathology and International Society of Urological Pathology Prostate Cancer Guidelines.
    Epstein JI; Kryvenko ON
    Eur Urol; 2021 Jan; 79(1):3-5. PubMed ID: 33189461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
    Egevad L; Delahunt B; Srigley JR; Samaratunga H
    APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.
    Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J
    Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.
    Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
    Pathology; 2015 Oct; 47(6):520-5. PubMed ID: 26325671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.
    van Leenders GJLH; van der Kwast TH; Grignon DJ; Evans AJ; Kristiansen G; Kweldam CF; Litjens G; McKenney JK; Melamed J; Mottet N; Paner GP; Samaratunga H; Schoots IG; Simko JP; Tsuzuki T; Varma M; Warren AY; Wheeler TM; Williamson SR; Iczkowski KA;
    Am J Surg Pathol; 2020 Aug; 44(8):e87-e99. PubMed ID: 32459716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
    Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
    Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head to head: should the intraductal component of invasive prostate cancer be graded?
    Varma M; Epstein JI
    Histopathology; 2021 Jan; 78(2):231-239. PubMed ID: 32692448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists.
    Smith SC; Gandhi JS; Moch H; Aron M; Compérat E; Paner GP; McKenney JK; Amin MB
    Adv Anat Pathol; 2021 Jan; 28(1):1-7. PubMed ID: 33027069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
    Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
    BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.
    Preisser F; Würnschimmel C; Pose RM; Heinze A; Steuber T; Michl U; Salomon G; Mandel P; Graefen M; Tilki D
    Prostate; 2022 Feb; 82(2):254-259. PubMed ID: 34807461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists.
    Berney DM; Algaba F; Camparo P; Compérat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Montironi R; Varma M; Egevad L
    Histopathology; 2014 Feb; 64(3):405-11. PubMed ID: 24102975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution, controversies and the future of prostate cancer grading.
    Egevad L; Delahunt B; Yaxley J; Samaratunga H
    Pathol Int; 2019 Feb; 69(2):55-66. PubMed ID: 30694570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
    Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K
    Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gleason Score 6 - Prostate Cancer or Benign Variant?
    Knüchel R
    Oncol Res Treat; 2015; 38(12):629-32. PubMed ID: 26633167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.